CACaption Management, LLC
Institutional investor · Portfolio as of Q3 2019
Top Holdings680 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
MEDICINES CO | 873,800 | $43.7M | 2.3% | — | — | — | Increased — |
PAYPAL HOLDINGS INC | 380,000 | $39.4M | 2.0% | — | — | — | New — |
MEDICINES CO | 682,400 | $34.1M | 1.8% | — | — | — | Increased — |
GW PHARMACEUTICALS PLC | 257,500 | $29.6M | 1.5% | — | — | — | Increased — |
MARATHON PETROLEUM CORP | 382,500 | $23.2M | 1.2% | — | — | — | Increased — |
HOME DEPOT INC | 100,000 | $23.2M | 1.2% | — | — | — | New — |
Biohaven Ltd. | 549,700 | $22.9M | 1.2% | — | — | — | Increased — |
SUNRUN INC | 1.3M | $22.4M | 1.2% | — | — | — | Increased — |
PAYPAL HOLDINGS INC | 215,000 | $22.3M | 1.2% | $101.96 | 0.00% | 1 qtr | New 65 |
HEWLETT-PACKARD CO | 1.1M | $20.7M | 1.1% | — | — | — | New — |
WELLCARE HEALTH PLANS INC | 77,800 | $20.2M | 1.0% | — | — | — | Increased — |
BEYOND MEAT INC | 130,000 | $19.3M | 1.0% | — | — | — | Unchanged — |
RINGCENTRAL INC | 150,000 | $18.9M | 1.0% | — | — | — | New — |
| 1.3M | $18.6M | 1.0% | — | — | — | New — | |
HEWLETT-PACKARD CO | 946,500 | $17.9M | 0.9% | — | — | — | New — |
uniQure N.V. | 452,200 | $17.8M | 0.9% | — | — | — | Decreased — |
HSBC HOLDINGS PLC-SPONS ADR | 450,000 | $17.2M | 0.9% | — | — | — | Increased — |
SUNRUN INC | 995,100 | $16.6M | 0.9% | — | — | — | Increased — |
SONY CORP-SPONSORED ADR | 275,000 | $16.3M | 0.8% | — | — | — | New — |
ALLERGAN PLC | 96,500 | $16.2M | 0.8% | — | — | — | New — |
Caption Management, LLC manages $1.9B across 680 positions as of Q3 2019. Top holdings: MDCO (2.3%), PYPL (2.0%), MDCO (1.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 143 new positions, 123 exits, 45 increased. Top move: PYPL (NEW, conviction 65). Portfolio: $1.9B across 680 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer